wallstreet-online.de
Expanded C-level team poised to accelerate development of NX-5948 in B cell malignancies
SAN FRANCISCO, May 28, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical ...
mehr ...
28. Mai 2024